Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-016024
Filing Date
2019-12-02
Accepted
2019-12-02 17:01:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28679
2 filename2.txt TEXT-EXTRACT 2082
  Complete submission text file 0000000000-19-016024.txt   42534
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filed for) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 7389 Services-Business Services, NEC